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Abstract
Targeted induction of double-strand breaks (DSBs) at natural endogenous loci was shown to increase the rate of gene
replacement by homologous recombination in mouse embryonic stem cells. The gene encoding dopachrome tautomerase
(Dct) is specifically expressed in melanocytes and their precursors. To construct a genetic tool allowing the replacement of
Dct gene by any gene of interest, we generated an embryonic stem cell line carrying the recognition site for the yeast I-SceI
meganuclease embedded in the Dct genomic segment. The embryonic stem cell line was electroporated with an I-SceI
expression plasmid, and a template for the DSB-repair process that carried sequence homologies to the Dct target. The I-SceI
meganuclease was indeed able to introduce a DSB at the Dct locus in live embryonic stem cells. However, the level of gene
targeting was not improved by the DSB induction, indicating a limited capacity of I-SceI to mediate homologous
recombination at the Dct locus. These data suggest that homologous recombination by meganuclease-induced DSB may be
locus dependent in mammalian cells.
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Introduction
The natural efficiency of the introduction of defined sequences
at specific locations of the mouse genome in embryonic stem (ES)
cells by homologous recombination (HR) varies between 10
25 and
10
28 events per treated cell. Such a frequency is too low to
consider the iterative introduction of a number of genes of interest
at a given locus in standard practice. This problem can be
overcome by enhancing recombination reactions at the target site
through the induction of a double-strand break (DSB) [1]. Such
DSBs can be induced with the yeast mitochondrial I-SceI
meganuclease which has an 18-bp recognition site, absent
normally in the mammalian genome but that may be added to
the genome of recipient cells. In previous studies performed with I-
SceI in Chinese hamster ovary (CHO) cells, mouse 3T3 fibroblasts,
PCC7-S multipotent cells, and also in several ES cell lines, specific
DSBs were shown to stimulate the repair of a tandem duplication
by intrachromosomal HR or gene targeting by plasmid-to-
chromosome HR [2–8]. More recently, plasmid-mediated gene
targeting was achieved in CHO cells after lentiviral delivery of the
I-SceI protein [9]. Expression of I-SceI was also shown to be
relevant to improve the efficiency of gene targeting in other
organisms, including flies and plants [10,11]. Based on these data,
it is generally admitted that a system based on the introduction of
an I-SceI recognition site close to the locus to be targeted in the
genome of recipient ES cells, combined with transient expression
of the I-SceI meganuclease to create a DSB, should enhance the
introduction of donor sequences at this site.
The Dct gene encodes the dopachrome tautomerase, a
melanogenic enzyme. In the embryo, Dct is expressed in pigment
cell precursors, i.e. melanoblasts, derived from the neural crest, in
cells of the retinal pigment epithelium and in the developing
forebrain [12,13]. In the adult epidermis, Dct is expressed in
pigment cells at all differentiation states: in stem cells that reside in
the bulge region of the hair follicle, in progenitors of the outer root
sheath and in melanocytes of the hair matrix [14]. Studies
performed in the mouse embryo with a LacZ reporter gene
expressed under the control of 3.4 kb of the Dct promoter (Dct-
LacZ transgene) depicted LacZ expression in melanoblasts and
melanocytes, in the retinal pigment epithelium, forebrain, dorsal
root ganglia and caudal nerves [15]. In addition, the Dct-LacZ
reporter allowed to monitor cells of the melanocyte lineage in
adult mice [16]. Altogether, Dct promoter-driven expression was
shown to mimic largely the endogenous expression pattern of the
gene. The Dct promoter has thus been used to drive the expression
of genes in melanocytes and their precursors in transgenic mice
[17–21]. However the use of combination of regulatory region
from Dct and the coding regions of exogenous genes, either
reporter genes or genes whose function is to be evaluated, can also
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to distinguish the specific expression of the transgene from ectopic
expression. Second, the transgene may be expressed in tissues that
do not normally express endogenous Dct. This has been repeatedly
observed with the Dct promoter [15,17,22]. It is worth noting that
Dct knockout mice are viable and fertile, and exhibit no defects,
with the exception of a diluted coat colour [23], making Dct an
interesting driver to monitor the effects of expression of genes of
interest, such as genes that may be involved in melanoma
progression [24,25]. Indeed, either homozygous knockin mice or
double heterozygotes for a reporter gene and the gene of interest
may be studied. We thus became interested by constructing a
genetic tool that would allow to insert with a high efficiency any
gene of interest in place of the Dct gene.
Our approach relied on the combination of three components:
an ES cell line carrying a Dct allele with the I-SceI recognition site,
an I-SceI expressing plasmid and a template for the DSB-repair
process carrying sequence homologies to the Dct locus. The
targeted integration at the Dct locus was tested after transfection of
both the I-SceI expressing plasmid and the repair construct in the
modified ES cell line. We report here that an I-SceI recognition site
embedded within the Dct gene sequence can be cleaved by
transiently expressed I-SceI meganuclease in ES cells. We further
show, contrary to expectations, and using two different repair
vectors, that I-SceI-mediated DSB did not increase the frequency
of HR at the Dct locus compared to conventional gene targeting
experiments.
Materials and Methods
Ethics Statement
Animals were housed in animal facilities accredited by the
French Ministry of Agriculture to perform experiments on live
mice, in appliance of the French and European regulations on care
and protection of the Laboratory Animals (accreditation number B
75 15-01 and B 75 15-07). The veterinary staff of the Institut
Pasteur animal facility approved protocols. Protocols were
performed in compliance with the NIH Animal Welfare Insurance
#A5476-01 issued on 02/07/2007.
Plasmids and Cells
Plasmid pPBSKlB#4 was given by I.J. Jackson (MRC,
Edinburgh, UK). Plasmids pL253, pL452, pSW23 were provided
by N. Copeland and N. Jenkins (Frederick, MD, USA). To obtain
pCAG-I-SceI, the enhancer of the major immediate-early enhanc-
er of the human cytomegalovirus (CMV) contained in pCMV-I-
SceI [26] was replaced by the chicken b-actin promoter and
cytomegalovirus enhancer [27]. CK35 ES cells [28] were grown
on mitomycin C-treated Neo
R primary fibroblasts in Dulbecco’s
modified Eagle’s Medium + GlutaMAX (Invitrogen) supplement-
ed with 15% fetal bovine serum, 0.1 mM b-mercaptoethanol
(Sigma), 10
3 U/ml murine LIF (PAA Laboratories) as previously
described [29].
Design of Repair Vectors
To insert an I-SceI recognition site at the Dct locus, a
replacement vector was constructed. A 6.5 kb SnabI-HincII
fragment from pPBSKlB#4 that contains 18 kb of Dct gene
(MGI:102563) [30] was inserted into the SpeI site of pL253 to
produce pL253-Dct plasmid. To introduce an I-SceI recognition
site and a Neo
R cassette into the 6.5 kb Dct fragment near the first
exon, we took advantage of a unique NheI site located within
intron 1, 112 bp downstream of the first exon. A 59 Dct fragment
containing the NheI site was amplified and flanked with KpnI and
EcoRI sites using the following primers: 59KpnI forward 59-
ATAGGTACCTCCCAATTAAGAAGGCATGG-39 and
59EcoRI reverse 59-GCGGAATTCCGCCTTTCTGAGTGAA-
GAG-39. The amplicon was inserted into pCR2.1 plasmid (TOPO
TA CloningH, Invitrogen). The I-SceI recognition site was added at
the NheI site. Besides, a 39 Dct fragment was amplified and flanked
with BamHI and SacII sites using the following primers: 39BamHI
forward 59-GTAGGATCCACCTTTGGCTTGTTTGTTGG-39
and 39SacII reverse 59-ATACCGCGGAGGACATGAGAACCC-
CAGA-39. The amplicon was inserted into a pCR2.1 plasmid.
pSW23 plasmid was digested by KpnI and SacII, and filled in with
the three fragments: the 59 KpnI-EcoRI fragment containing the I-
SceI site, an EcoRI-BamHI Neo
R cassette from pL452 plasmid and
the 39 BamHI-SacII fragment. The replacement vector was
produced by a recombineering reaction between the modified
pSW23 and pL253-Dct plasmid. The replacement vector carries a
herpes simplex virus-thymidine kinase (HSV-TK) negative selec-
tion cassette downstream of the 6.5 kb Dct fragment.
The construction of HR repair vectors HR1 and HR2 relied
on the GatewayH technology (Invitrogen). Entry and destination
vectors were produced. pENTR1A entry vector (Invitrogen)
contains ccdB flanked with multi-cloning sites (MCS). The SV40
polyadenylation sequence (pA) was inserted at the EcoRV site to
give pENTR1ApA. The Lago1 gene, a synthetic CpG-free LacZnls
reporter gene that contains a SV40 nuclear localization signal
(Invivogen), with its start codon was inserted in pENTR1ApA in
place of ccdB (Fig. 1). The first destination vector (DV1) was
constructed as follows. Starting from pL253-Dct plasmid, a SexAI-
AvrII 400 bp fragment containing the ATG start codon was
removed from Dct sequence. A linker made of the following
primers was used to fill the gap in Dct sequences: HpaPme
forward 59-CTAGGTTAACGTTTAAA-39 and HpaPme reverse
59-CCTGGTTTAAACGTTAAC-39. The linker allowed the
insertion of a unique HpaI recognition site into pL253-Dct,
giving pL253-Dct-HpaI plasmid. To insert the Neo
R cassette into
pL253-Dct-HpaI, a recombineering reaction was performed and
gave pL253-Dct-HpaI-Neo
R plasmid. Finally, a reading frame
cassette A (RfA) (GatewayH technology) that contains the Cm
R-
ccdB cassette flanked by attR1 and attR2 sites, was inserted at the
HpaI site into pL253-Dct-HpaI-Neo
R to obtain DV1. In DV1, the
negative selection cassette HSV-TK from pL253 is downstream
of the 39 sequence homology of Dct (Fig. 1). To produce the first
repair vector (HR1), the Cm
R-ccdB cassette in DV1 was replaced
by Lago1 gene using LR reaction (GatewayH technology) (Fig. 1).
To remove the short regions of homology between the HR1
repair vector and the first intron of Dct gene, a second destination
vector (DV2) was produced. The H2B-mCherry reporter gene with
its start codon [31] was inserted in place of ccdB in pENTR1ApA
entry vector (Fig. 2). To obtain DV2, a 2.8 kb AvrII-Bsu36I
fragment was synthetized. It contains a Neo
R cassette framed with
FRT sites and 1 kb of Dct genomic sequence. A 1 kb AvrII-Bsu36I
fragment was removed from the pL253-Dct-HpaI plasmid and
replaced by the 2.8 kb synthetized AvrII-Bsu36I fragment. Then
RfA was ligated at the HpaI site. Figure 2 shows the map of DV2.
To produce the second repair vector (HR2), the Cm
R-ccdB cassette
of DV2 was replaced by the H2B-mCherry sequences using LR
reaction (Fig. 2). The integrity of the repair vectors was verified by
sequence analysis.
Homologous Recombination Assay
To insert a unique I-SceI site at the Dct locus, approximately
1.6 6 10
7 CK35 ES cells were electroporated with the NotI-
linearized replacement vector. G418 (300 mg/mL) was added
48 h after plating for 12 days and gancyclovir (2 mM) was
Homologous Recombination at the Dct Locus
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R cassette was
removed using pIC-Cre plasmid [32] in which the transcription
of Cre recombinase is driven by a synthetic HSV-TK promoter
and enhancer. Fifteen micrograms of pIC-Cre plasmid were
electroporated into approximately 1610
7 ES clone 4 cells and
the cells were cultured without G418. For the gene targeting
with HR1 repair vector, approximately 1.3610
7 MF1 ES cells
were electroporated with 20 mg of supercoiled HR1 alone or
with 33 mg pCMV-I-SceI [26] or 37.5 mg pCAG-I-SceI. The
ratio of expression plasmid to repair vector was 5 to 1. For the
experiment using HR2, approximately 1.6610
7 MF1 ES cells
were electroporated with 30 mg of supercoiled HR2 plasmid
alone or with either 11 mg pCMV-I-SceIo r1 3mg pCAG-I-SceI
expression plasmids. The ratio of expression plasmid to repair
vector was 1 to 1. Approximately 1.6610
7 MF1 ES cells were
independently electroporated with 30 mgo fNotI-linearized HR2
plasmid, as a control.
DNA Analysis in Selected Clones
Genomic DNAs of ES clones obtained after selection with G418
and gancyclovir were digested with BamHI. Correct gene targeting
was analyzed by Southern blot using a 1 kb 59 external probe
produced by PCR amplification with the following primers:
5DCTF forward 59-TTGGGGTCAGGGAGATACAG-39 and
5DCTR reverse 59-TGAGCAGCAGTGAAGTTTGG-39.
Generation of Dct
I-SceI/+ Mice. Two independent Dct
I-SceI/
+129/Sv ES clones, named MF1 and MF2, were introduced into
C57BL/6N blastocysts, which were transferred to pseudo-preg-
nant C57BL/6N females. Male chimeras (129/Sv Dct
I-SceI/+ ,-.
C57BL/6N Dct
+/+) were mated with C57BL/6N females. The
progeny was genotyped at the Dct locus to evaluate the percentage
of Dct
I-SceI/+ mice.
Ligation-Mediated PCR (LM-PCR) Analysis
Approximately 1.6 6 10
7 MF1 ES cells were electroporated
with 50 mg pCMV-I-SceI, pCAG-I-SceI or mock plasmid. Four
hours later, genomic DNA was extracted. Two micrograms of
genomic DNA from MF1 cells transfected with the mock plasmid
were digested with PstIo rI - SceI and precipitated. LM-PCRs were
performed with these PstI- and I-SceI-digested DNAs, and with
undigested DNA from MF1 cells transfected with mock plasmid,
pCMV-I-SceI or pCAG-I-SceI. The specific LM-C1 primer 59-
AATTCTTCAACCGGACAT-39 was used for the first extension.
The asymmetrical synthetic double-stranded linker was prepared
by hydridization of two oligonucleotides: linkerF forward 59-
GCGGTGACCCGGGAGATCTGAATTC-39 and reverse lin-
kerR 59-GAATTCAGATC-39. The specific LM-C2 primer 59-
CGGACATGCAAATGCACAGGTGAGG-39 was used for a
first PCR amplification. The PCR product was subjected to nested
PCR with the specific LM-C3 primer 59-CCCTTGGGCA-
GACCCAGATGTCACT-39) and linkerF. After agarose gel
electrophoresis and alkaline transfer to a nylon membrane, the
DNA was hybridized to the specific 36-mer radioactive probe LM
59-CTTCTGAGGAGAGGCGACACTGGTGA-
CAAACTGTTA-39.
Figure 1. Construction of the HR1 repair vector. The pENTR1ApA entry vector is represented in the upper left. Black circles flanking ccdB
represent multi-cloning sites (MCSs). The SV40 polyadenylation sequence (pA) was introduced at the 39 end of the ccdB gene, before attL2 sequence.
The entry vector contains a Kan
R cassette conferring resistance to kanamycin in E. coli. The entry vector carrying Lago1 gene is represented in the
upper right. The destination vector (DV1) contains 1.4 and 4.5 kb of Dct homologous arms depicted as grey rectangles. DV1 also contains the Neo
R
and HSV-TK cassettes used in cell culture, and an Amp
R cassette conferring resistance to ampicillin in E. coli. The repair vector (HR1) is produced by LR
reaction, allowing the replacement of Cm
R-ccdB cassette by the Lago1 gene.
doi:10.1371/journal.pone.0039895.g001
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Our experiments aimed at testing the efficiency of a ready-to-
use tool to produce ES cells, and eventually mice, carrying any
sequence of interest inserted in place of the Dct gene. Our strategy
relied on the reported stimulation of gene targeting frequency at a
natural locus associated with a DSB induced by the yeast
meganuclease I-SceI in ES cells [3]. We performed a two-step
experiment. In a first step, the I-SceI restriction site was inserted to
the Dct gene in ES cells using conventional gene targeting
procedures. The Dct gene carrying a unique I-SceI restriction site
was thus considered as a preferential target for HR. In a second
step, an I-SceI-expression plasmid was introduced together with a
repair vector sharing a 5.9-kb of Dct isogenic DNA by
electroporation in the engineered ES cells, and the efficiency of
gene targeting at the Dct locus was assayed.
Production of a New Target Allele at the Dct Locus in ES
Cells
As a first step, the I-SceI restriction site was inserted within Dct
intron 1 in ES cells. A replacement vector containing a unique I-
SceI restriction site, a positive selection (Neo
R) cassette flanked by
loxP sites, and 1.9 and 4.5 kb of 59 and 39 genomic sequences from
the Dct gene was constructed. A negative selection cassette (HSV-
TK) was added after the 39 homology arm (Fig. 3A). The
replacement vector was linearized and electroporated into CK35
ES cells. The cells were cultured in the presence of G418 and
gancyclovir. Out of 107 G418- and gancyclovir-resistant colonies,
one clone (ES clone 4) was correctly targeted with the replacement
vector as shown by PCR (data not shown), and later confirmed by
Southern blot analysis (Fig. 3B). To test whether the meganuclease
I-SceI is able to specifically cleave the new Dct
I-SceI-Neo allele,
genomic DNA of the ES clone 4 was treated with both BamHI and
I-SceI restriction enzymes. Southern blot analysis using an external
59 probe revealed the 4.5 kb BamHI-I-SceI distinctive fragment,
indicating that the I-SceI site inserted at the Dct locus was indeed
cut in vitro by the meganuclease (Fig. 3C).
To delete the Neo
R cassette, a Cre recombinase-expressing
plasmid (pIC-Cre) was electroporated into clone 4 Dct
I-SceI-Neo/+ ES
cells. A preliminary experiment indicated that more than 30% of
the cells transfected with pIC-Cre plasmid died in presence of
G418, presumably because they had lost the Neo
R cassette. pIC-
Cre plasmid was electroporated into Dct
I-SceI-Neo/+ ES cells and the
cells were cultured without G418. Twenty-four clones were picked
up and their sensitivity was assessed by adding G418 on a
duplicate plate: 8 clones were Neo
S. All eight clones had lost the
Neo
R cassette as shown by PCR analysis (data not shown). Two
ES clones (MF1 and MF2) were further selected on morphological
criteria. Southern blot analysis further confirmed the deletion of
the Neo
R cassette in MF1 and MF2 clones (Fig. 3D).
To test whether Dct
I-SceI/+ MF1 and MF2 clones are able to
colonize the germ line, we injected MF1 and MF2 cells into
C57BL/6N blastocysts, and thereafter transferred the embryos to
pseudo-pregnant females. Twelve and ten chimeras were pro-
duced from MF1 and MF2 cells, respectively. Altogether 18
chimeras were more than 95% chimeric, based on their coat
colour pattern. Several male chimeras were mated to C57BL/6N
females. Half of their progeny was Dct
I-SceI/+, indicating that the
Figure 2. Construction of the HR2 repair vector. The pENTR1ApA entry vector is represented in the upper left. The entry vector containing the
H2B-mCherry gene is represented in the upper right. The DV2 destination vector contains the Dct homologous arms, 1.4 and 4.5 kb in length,
depicted as grey rectangles. The black circle denotes 109 bp of Dct intron absent in DV1 destination vector that were inserted in DV2 destination
vector. DV2 also contains a Neo
R cassette flanked with FRT sites depicted as white diamond symbols. The repair vector (HR2) is produced by LR
reaction, allowing the replacement of Cm
R-ccdB cassette by the H2B-mCherry gene.
doi:10.1371/journal.pone.0039895.g002
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line.
Insertion of Lago1 at the Dct Locus
We wished to repeatedly introduce gene of interest at the Dct
locus. As a first attempt, we used the Lago1 gene. The HR1 repair
vector contained Lago1, a Neo
R cassette framed with loxP sites, two
regions of homology with the Dct
I-SceI allele, 1.4 and 4.5 kb in
length, and a HSV-TK negative selection cassette (Fig. 4A). The
construction of the HR1 repair vector relied on the GatewayH
technology (see Materials and Methods, and Fig. 1). We assessed
the rate of insertion of Lago1 gene at the Dct locus following DSB-
induced HR. MF1 ES cells were electroporated with supercoiled
HR1 either with or without an I-SceI expressing plasmid. Two
different I-SceI-expressing plasmids were tested: (i) pCMV-I-SceIi n
which I-SceI expression is driven by the cytomegalovirus promoter
[3,26], and (ii) pCAG-I-SceI, where I-SceI is expressed under the
control of the CAG composite promoter (see Materials and
Methods). The cells were exposed to G418 and gancyclovir. A
total of 215, 235 and 252 colonies resistant to both antibiotics were
obtained when MF1 ES cells were transfected with HR1 alone,
and in combination with pCMV-I-SceI or pCAG-I-SceI respec-
Figure 3. Production of a new target allele at the Dct locus. (A) Introduction of an I-SceI site at the Dct locus. From top to bottom are
represented the Dct wild-type allele (Dct
+), the replacement vector, the Dct
I-SceI-Neo targeted allele, and the Dct
I-SceI allele produced after deletion of
the Neo
R cassette. The grey boxes represent exons 1 and 2 of the Dct gene. The black circle represents 109 bp of Dct intron 1 sequence that are lost
during an homologous recombination event. The horizontal black bar represents the external 59 probe used for the Southern blots. The Neo
R and
HSV-TK cassettes are depicted as white rectangles. loxP sites are represented by white triangles. The Dct homologous arms, 1.9 and 4.5 kb in length,
are denoted as grey rectangles. I-SceI and BamHI restriction sites are indicated. (B) Southern blot analysis of Dct
+/+ ES cells and targeted ES cells (clone
4). Genomic DNAs of ES cells were digested with BamHI. The 11.7 and 6.4 kb fragments are distinctive of the Dct
+ and Dct
I-SceI-Neo alleles, respectively.
(C) Test of the ability of I-SceI meganuclease to specifically cleave Dct
I-SceI-Neo/+ ES cells. Southern blot analysis of Dct
+/+ ES cells and clone 4. Genomic
DNAs were digested with I-SceI and BamHI. The 4.5 kb fragment is distinctive of the Dct
I-SceI-Neo allele. (D) Southern blot analysis of Dct
+/+ ES cells,
clone 4, MF1 and MF2 clones. Genomic DNAs were digested with BamHI. The 4.5 kb fragment is distinctive of the Dct
I-SceI allele.
doi:10.1371/journal.pone.0039895.g003
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individually picked up and PCR tested. Transfection with either
HR1 alone or with HR1 and pCMV-I-SceI gave no targeted
colonies. Transfection with HR1 and pCAG-I-SceI gave a positive
PCR signal (data not shown), which was confirmed by Southern
blot analysis (Fig. 4B and data not shown). Thus gene targeting
using the HR1 repair vector and pCAG-I-SceI led to a frequency
of HR that could be estimated at 1.4 6 10
27 events per treated
cell. This frequency is not higher than that obtained with the
conventional gene targeting procedures (generally range between
10
25 and 10
28 events per treated cell).
Elliott and colleagues (1998) reported previously that, in I-SceI-
induced gene targeting with a transfected circular plasmid, the
majority of recombination events occurred within 100 bp from the
cleavage site [33]. Actually, the HR1 repair vector contains two
short regions of homology with the targeted Dct
I-SceI allele next to
the I-SceI site. These regions are shown in Figure 4C. In the Dct
I-
SceI allele, the first short region of homology is located between
exon 1 of the Dct gene and the I-SceI site. It encompasses 58 bp of
Dct intron 1 sequence. Still in the Dct
I-SceI allele, a second region of
homology is located between I-SceI site and the end of loxP site. It
encompasses 125 bp of Dct intron 1 sequence and loxP sequence.
In HR1 repair vector, both 58 bp and 125 bp regions are located
between the attB2 site and the Neo
R cassette. We hypothesized
that these homology regions, 183 bp in total length, could be used
as an efficient repair template and would produce by HR a
recombinant allele harbouring neither a Lago1 gene nor a Neo
R
cassette (Fig. 4C). Hence, clones that have undergone HR would
die in the presence of G418.
Insertion of H2B-mcherry at the Dct Locus
We thus decided to remove the two short regions of homology
(including the loxP site) and to construct a novel repair vector.
Therefore, a second destination vector (DV2) was produced using
the H2B-mCherry reporter gene [31]. The HR2 repair vector was
constructed (Fig. 2). It carries H2B-mCherry, a Neo
R cassette
flanked with FRT sites, two regions of homology with the Dct
I-SceI
allele, 1.4 and 4.5 kb in length, and a HSV-TK negative selection
cassette (Fig. 5A). By contrast with HR1, HR2 displays neither a
short region of homology with the Dct gene next to the I-SceI site
nor a loxP site.
We assessed the rate of targeted insertion of H2B-mCherry at the
Dct locus by I-SceI-induced HR. MF1 ES cells were electroporated
with supercoiled HR2 plasmid alone or with either pCMV-I-SceI
Figure 4. Lago1 gene targeting by HR at the Dct locus. (A) Insertion of Lago1 gene at the Dct locus. The Dct
I-SceI allele, the HR1 repair vector and
the Dct
Lago1-Neo targeted allele are represented from top to bottom. A lightning denotes I-SceI expression from pCMV-I-SceI or pCAG-I-SceI plasmid.
The 1.4 and 4.5 kb of Dct isogenic DNA are depicted by grey rectangles. (B) Southern blot analysis of Dct
+/+, Dct
I-SceI/+ and Dct
Lago1-Neo/+ ES cells.
Genomic DNAs were digested with BamHI. The probe used for the hybridization is the external 59 probe depicted by a black bar. The 11.7, 4.5, and
10.1 kb fragments are distinctive of the Dct
+, Dct
I-SceI, and Dct
Lago1-Neo alleles, respectively. (C) Diagram of DSB-induced homologous recombination
with no insertion of the Lago1 gene. The Dct
I-SceI allele, and the HR1 repair vector are represented from top to bottom. The short regions of homology,
58 bp and 125 bp in length, between the HR1 repair vector and the genomic DNA at the Dct locus in Dct
I-SceI/+ cells, are depicted by grey rectangles.
An HR between these two short regions of homology would lead to loss of the I-SceI site with no integration of the Neo
R cassette. The resulting cells
would die in the presence of G418.
doi:10.1371/journal.pone.0039895.g004
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control, MF1 ES cells were electroporated with linearized HR2
plasmid. The cells were cultured in the presence of G418 and
gancyclovir. Colony counting revealed 397 and 370 colonies in
presence of pCMV-I-SceI and pCAG-I-SceI plasmids respectively,
and 653 colonies in the absence of the meganuclease (Table 1).
Electroporation with linear HR2 plasmid, representative of a
conventional gene targeting experiment, revealed 635 resistant
colonies to both antibiotics. For each experiment, 144 colonies
were individually picked up, amplified and PCR tested. Electro-
poration with linear HR2 plasmid resulted in one targeted clone
(clone 7E). No targeted clones were seen in the supercoiled HR2-
electroporated MF1 ES cells. The same results were obtained in
the MF1 ES cells electroporated with both supercoiled HR2 and
pCMV-I-SceI plasmids. Electroporation with HR2 and pCAG-I-
SceI led to one targeted clone (clone 11E). Both conventional
(linear HR2) and I-SceI-mediated (supercoiled HR2 and pCAG-I-
SceI) gene targeting HR were confirmed by Southern blot analysis
(Fig. 5B). Thus gene targeting using the HR2 repair vector and
pCAG-I-SceI led to a frequency of HR that could be estimated at
1.6610
27 events per treated cell whereas conventional gene
targeting led to a frequency of 2.7610
27 events per treated cell.
Therefore, the I-SceI-induced DSB strategy does not seem to
improve the frequency of HR at the Dct locus.
Transient Expression of I-SceI Triggers DSB in Dct
I-Scei/+ ES
Cells
To test whether the meganuclease could indeed trigger DSB in
vivo at the Dct locus in Dct
I-SceI/+ ES cells, we electroporated I-SceI-
expressing plasmids into MF1 ES cells and assayed the DNA lesion
at the I-SceI site using a sensitive technique, known as ligation-
mediated PCR (LM-PCR), that allows the specific detection of
Table 1. Frequency of homologous recombination at the Dct locus.
Repair vector and
conformation
I-SceI-expressing
plasmid
Total electroporated
cells
Total G418
r
gancyclovir
r
Analyzed G418
r
gancyclovir
r
Targeted
integration
Gene targeting
frequency
HR1 circular None 13610
6 215 136 0 0
CMV-I-SceI1 3 610
6 235 136 0 0
CAG-I-SceI1 3 610
6 252 136 1 1.4610
27
HR2 circular None 16610
6 653 144 0 0
CMV-I-SceI1 6 610
6 397 144 0 0
CAG-I-SceI1 6 610
6 370 144 1 1.6610
27
HR2 linear None 16610
6 635 144 1 2.7610
27
doi:10.1371/journal.pone.0039895.t001
Figure 5. H2B-mCherry gene targeting by HR at the Dct locus. (A) Insertion of H2B-mCherry gene at the Dct locus. The Dct
I-SceI allele, the HR2
repair vector and the Dct
H2B-mCherry-Neo allele are represented from top to bottom. AvrII sites are indicated. There are no homologous sequences
between Dct
I-SceI and HR2 close to the I-SceI site. A lightning denotes I-SceI expression from pCMV-I-SceI or pCAG-I-SceI plasmid. The 1.4 and 4.5 kb of
Dct isogenic DNA are depicted by grey rectangles. (B) Southern blot analysis of Dct
+/+, Dct
I-SceI/+ES cells, and Dct
H2B-mCherry-Neo/+ ES clones 7E and 11E.
ES clones 7E and 11E were obtained after transfection with the linear HR2 repair vector, and with both the supercoiled HR2 repair vector and pCAG-I-
SceI expression plasmid, respectively. Genomic DNAs were digested with AvrII. The probe used for the hybridization is the external 59 probe depicted
by a black bar. The 3.9 kb fragment is carried by the Dct
+ and Dct
I-SceI alleles, and the 6.5 kb fragment is distinctive of the Dct
H2B-mCherry-Neo targeted
allele.
doi:10.1371/journal.pone.0039895.g005
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pCAG-I-SceI and a mock plasmid were independently electropo-
rated into MF1 ES cells and four hours later the genomic DNAs
were extracted.
In a first step, we tested the specificity and sensibility of the LM-
PCR on transfected ES cells. We used two sites recognized by
restriction endonucleases: (i) the I-SceI site, whose cleavage was
under evaluation; (ii) a PstI site at position +52 relative to the I-SceI
site. Approximately 2 mg of extracted genomic DNA from mock
plasmid-transfected Dct
I-SceI/+ MF1 ES cells were digested with PstI
or I-SceI restriction endonuclease respectively. Then the digested
DNA was heated to allow annealing with a first Dct gene-specific
primer (LM-C1) located at position -185 relative to the I-SceI site.
This was followed by LM-C1 primer extension that terminated at
the site of a break to produce a blunt-ended DNA, which was then
ligated to an asymmetrical synthetic double-stranded linker. The
newly synthesized DNA molecule was denatured to allow
annealing with a second Dct gene-specific primer (LM-C2) located
at position -174 relative to the I-SceI site and amplification in a
PCR reaction with linker primer. The PCR-amplified products
were exponentially amplified by nested PCR using a third Dct-
gene-specific primer (LM-C3) located at position 2148 relative to
the I-SceI site and linker primer, as shown in Fig. 6A. Finally, the
PCR products were separated on an agarose gel, alkaline blotted
to a nylon membrane, and hybridized with a radioactive probe
which does not overlap the primer sequences. PCR products of the
predicted sizes, 148 bp for I-SceI digestion and 200 bp for PstI
digestion, were seen (Fig. 6B). These data indicate that the LM-
PCR technique allowed the specific detection of a cleavage
generated in vitro on the genomic DNA from MF1 ES cells.
In a second step, we evaluated the ability of the meganuclease to
trigger a DSB in vivo at the Dct locus. Approximately 2 mgo f
extracted genomic DNA from mock plasmid-transfected MF1 ES
cells, pCMV-I-SceI- transfected MF1 ES cells and pCAG-I-SceI-
transfected MF1 ES cells were directly analyzed by LM-PCR.
Figure 6C shows that no DNA lesions occurred at significant level
at the I-SceI site in the absence of I-SceI expression. When the
genomic DNA from pCMV-I-SceI-transfected MF1 ES cells was
used as a template in the LM-PCR reaction, a 148 bp
amplification product was detected, showing that expression of
the meganuclease in MF1 ES cells triggered DSB at the I-SceI
restriction site. LM-PCR in which the genomic DNA from pCAG-
I-SceI-transfected cells was used as a template produced similar
results (Fig. 6C), suggesting that both I-SceI expression vectors were
equally efficient in triggering DSB at the target locus.
Discussion
In this report, we provided evidence that I-SceI-induced DSB in
ES cells does not improve the efficacy of the gene targeting
methodology at the Dct locus compared to the conventional
approach. Electroporation was used to introduce the I-SceI
expressing plasmids into ES cells and a low efficiency of
transfection could explain these results. However, we were able
to detect the expression of enhanced green fluorescent protein
(GFP) from Aequora victoria by fluorescence-activated cell sorter
(FACS) analysis in 65% of a population of CK35 ES cells
electroporated with a plasmid containing the CMV promoter
driving the expression of the GFP, indicating efficient electropo-
ration (data not shown). These data agree with a previous report
[35]. Both repair vectors (HR1 and HR2) contain 5.9 kb of Dct
homology. The same homology was used previously by Guyon-
neau et al. [23] to inactivate the Dct gene in ES cells, indicating
that such a length is efficient for a gene replacement event.
However, we cannot exclude that increasing the length of
homology may improve I-SceI-mediated HR at the Dct locus.
Since the first repair vector (HR1) contained short regions of
homology in the vicinity of the I-SceI site, we hypothesized that
these regions were preferentially used to repair the DSB, thus
generating homologous recombinant clones that did not integrate
the Neo
R cassette and died eventually in the presence of G418.
Therefore, a second repair vector (HR2) with no homology to the
sequence surrounding the I-SceI site was generated, but we still
failed to demonstrate improvement of the frequency of gene
targeting.
Previous experiments suggested that non-homologous recombi-
nation may be more efficient than plasmid-to-chromosome HR to
repair a chromosomal DSB introduced by I-SceI. Indeed, when
mouse Ltk
- fibroblasts carrying a selectable herpes simplex virus
thymidine kinase (tk) gene mutated by the 18-bp I-SceI site, were
electroporated with I-SceI meganuclease and a repair plasmid with
the functional tk gene, tk
+ clones were recovered. However, all
analyzed tk
+ cells contained deletions that restored the reading
frame of the tk gene, indicating that the recovery of a functional tk
gene did not occur through HR of the integrated tk gene with a
transfected tk fragment, but rather via resection and ligation [36].
These data were obtained in mouse Ltk
2 fibroblasts, not in ES
cells. This deserves mention since distinct differences in frequen-
cies of targeted integration driven by a DSB among cell types have
been reported. HR after cleavage by a zinc-finger nuclease (ZFN)
at the CCR5 locus in presence of cognate donor linear and circular
episomes was more efficient in a panel of immortalized cell lines
from human leukemia than in human stem cells, such as cord
blood CD34
+ hematopoietic cells and human ES cells [37]. It has
also been reported that the rate of ZFN-mediated gene targeting at
the Rosa26 locus was higher in primary fibroblasts from adult mice
than in murine ES cells [38]. These results suggest that DSB-
induced gene targeting may be lower in ES cells than in somatic
cells. This contention seems inconsistent with reports showing that
HR is the predominant pathway to repair DSBs in ES cells,
whereas somatic cells utilize non-homologous end joining (NHEJ)
[39,40]. It has also been reported that ES cells that had been
allowed to differentiate preferred the error-prone NHEJ pathway
to the high-fidelity HR to repair DNA DSBs [39]. Because ES cells
and somatic cells are intrinsically different in the extent to which
they preserve their genomic integrity [41], it was important to
assess that our experiments were made with genuine ES culture
rather than differentiated ES culture. We confirmed that the
Dct
I2SceI/+ CK35 cells are truly pluripotent ES cells, able to
colonize the germ line. Furthermore, CK35 ES cells have been
previously used to demonstrate highly efficient gene targeting after
DSB [3].
We observed that the repair vector was not inserted at the Dct
locus in the majority of neomycin- and gancyclovir-resistant
clones. One possible explanation was that I-SceI did not cleave its
recognition sequence in Dct
I2SceI/+ ES cells. However, we showed
here the existence of I-SceI-induced DSBs at the Dct locus using
LM-PCR. This result does not rule out the possibility that the
efficiency of cleavage by I-SceI is an important factor to favor HR
at a given individual locus. Recent findings by Daboussi et al. [42]
support this conclusion. They found that chromatin accessibility
modulates the ability of meganucleases to induce targeted gene
modification in human 293-H cells.
Seminal experiments of gene targeting in ES cells based on an I-
SceI-induced gene replacement system were first performed with
mutated resistance genes integrated in chromosomal sequences
[8], and later extended to natural endogenous genes, Hprt, Villin
and Dbx1 genes [3,4,43]. Importantly, random integrations could
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mouse ES cells when selection strategies were specifically designed
to single out the gene targeting events and eliminate the
nonrecombinant recombination events [3,4,8]. Altogether, the
number of actual genes that have been efficiently targeted
following I-SceI-mediated HR in ES cells is still limited. It is
widely accepted that the efficiency of conventional HR depends on
the target locus. Our results suggest that, similarly, efficiency of
gene correction by DSB-induced HR may be highly dependent on
the targeted locus. We anticipate that deeper analysis of the
meganuclease, repair vector, target locus and cells that do not
show enhanced HR by DSB may also shed light on the nature of
the factors that contribute to gene targeting in mammalian cells.
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